| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $53.5M | +31.6% |
| SG&A Expense | $25.4M | -6.6% |
| Operating Income | -$78.9M | -16.3% |
| Pre-tax Income | -$72.5M | -10.6% |
| Income Tax | $0 | — |
| Net Income | -$74.6M | -11.9% |
| EPS (Basic) | -$1.84 | +12.0% |
| EPS (Diluted) | -$1.84 | +12.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.5M | -57.0% |
| Short-term Investments | $85.4M | -23.7% |
| Current Assets | $114.8M | -36.0% |
| Total Assets | $115.6M | -35.9% |
| Current Liabilities | $9.3M | -13.8% |
| Total Liabilities | $9.4M | -15.1% |
| Stockholders' Equity | $106.2M | -37.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.3M | -5.2% |
| Capital Expenditures | $12K | -77.8% |
| Investing Cash Flow | $27.7M | +124.7% |
| Financing Cash Flow | $143K | -99.7% |
| Free Cash Flow | -$60.3M | -5.1% |